1335.7000 5.70 (0.43%)
NSE Apr 08, 2026 15:31 PM
Volume: 3.3M
 

Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. has an average target of 1362.22 from 9 brokers.
More from Aurobindo Pharma Ltd.
Recommended